- Study at Deakin
- Campus life
- Industry and community
- About Deakin
Deakin's partnership with Biocon Ltd - one of India's largest biotechnology company - was formalised in June 2007 with the signing of a Memorandum of Understanding (MOU).
Under the terms of the MOU, the two organisations have agreed to collaborate and assist each other on a number of projects. A key priority is the establishment of a Deakin India Research Institute (DIRI) in Bangalore which will also involve collaborative research with Biocon.
The relationship between Biocon and Deakin is not only about science and communication, but also about mutual support to develop both organisations in Australia and India with staff and student exchanges.
The proposed Institute will focus on transformational science and technologies at the intersection of bio, nano and info approaches to drug development, biotechnology, new materials production and intelligent systems.
The Institute will be closely linked to Deakin's Institute of Technology Research and Innovation in Geelong - an over-arching Research Institute that encompasses Deakin's Centre for Fibre and Material Innovative, Intelligent Systems Group, and Institute of Biotechnology.
The MOU will also see Deakin, via its Metabolic Research Unit, undertaking research into metabolic diseases on behalf of Biocon.
A critical component of the success of the partnership between Deakin and Biocon is the support of both governments in India and Australia.